Yüklüyor......
De novo MET amplification promotes intrinsic resistance to first-generation EGFR tyrosine kinase inhibitors
First-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) could induce dramatic tumor responses in non-small-cell lung cancer patients with EGFR-activating mutations. However, a small proportion of patients have no tumor response on initial EGFR TKI treatment with an...
Kaydedildi:
| Yayımlandı: | Cancer Biol Ther |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6741769/ https://ncbi.nlm.nih.gov/pubmed/31131689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2019.1617568 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|